戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                 In addition, CD-MPR binding affinities are modulated by divalent cati
2 ouble mutants, mice lacking IGF2R/CI-MPR and CD-MPR survive in an IGF-II null background at a very lo
3 nt mannose 6-phosphate receptors (CI-MPR and CD-MPR) for high mannose-type N-glycans of defined struc
4 ion of phosphorylated glycans by the CI- and CD-MPRs has implications for understanding the biosynthe
5       A detailed comparison of the available CD-MPR structures reveals the positional invariability o
6 of the extracytoplasmic domain of the bovine CD-MPR (residues 3-154) complexed with mannose 6-phospha
7 on the extracytoplasmic domain of the bovine CD-MPR.
8 e roles of the Mr = 46,000 cation-dependent (CD-) MPR and the Mr = 300,000 cation-independent (CI-) M
9  controls for these cells, we also expressed CD-MPR trafficking mutants that either localize to the p
10              Mouse L cells stably expressing CD-MPRs with mutations that enhance GGA binding sorted c
11 its ligands is pH-dependent; the homodimeric CD-MPR binds lysosomal enzymes optimally in the pH envir
12 APP-overexpressing murine L cells with human CD-MPR.
13 sosomal hydrolases resulting from changes in CD-MPR expression affects amyloid precursor protein (APP
14 ta42 into the growth media nearly tripled in CD-MPR- and CD-MPRendo-expressing cells when compared wi
15 imilar to those reported for the full-length CD-MPR, demonstrating that the extracellular region of t
16      The two MPRs, the cation-dependent MPR (CD-MPR) and the insulin-like growth factor II/cation-ind
17  receptors (MPRs), the cation-dependent MPR (CD-MPR) and the insulin-like growth factor II/MPR (IGF-I
18 CI-MPR) and the 46 kDa cation-dependent MPR (CD-MPR) are key components of the lysosomal enzyme targe
19 CI-MPR) and the 46-kDa cation-dependent MPR (CD-MPR) are type I integral membrane glycoproteins that
20         Following metabolic labeling, mutant CD-MPRs were tested for their ability to bind pentamanno
21                                Expression of CD-MPR resulted in a partial redistribution of a represe
22            In addition, saturating levels of CD-MPR resulted in the precipitation of only 50% of the
23 tion-dependent mannose 6-phosphate receptor (CD-MPR) and the insulin-like growth factor II/cation-ind
24 tion-dependent mannose 6-phosphate receptor (CD-MPR) contains a signal(s) that prevents the receptor
25 tion-dependent mannose 6-phosphate receptor (CD-MPR) encoding only the extracytoplasmic region, Stop1
26 tion-dependent mannose 6-phosphate receptor (CD-MPR) is a key component of the lysosomal enzyme targe
27 tion-dependent mannose 6-phosphate receptor (CD-MPR) plays a key role in the delivery of lysosomal en
28 tion-dependent mannose 6-phosphate receptor (CD-MPR), which is partially localized to early endosomes
29 with different concentrations of recombinant CD-MPR or soluble CI-MPR.
30                                          The CD-MPR bound weakly or undetectably to the phosphodieste
31 ncountered by the receptor including: 1) the CD-MPR bound at pH 6.5 (i.e. trans Golgi network) to a h
32 )Man(alpha1,2)Man-O-(CH(2))(8)COOMe), 2) the CD-MPR at pH 4.8 in an unbound state (i.e. endosome), an
33 an unbound state (i.e. endosome), and 3) the CD-MPR at pH 7.4 (i.e. cell surface).
34 aphic studies have shown that at pH 6.5, the CD-MPR bound to Man-6-P adopts a significantly different
35 fied as essential for Man-6-P binding by the CD-MPR and domains 1-3 and 9 of the CI-MPR.
36 ssential for carbohydrate recognition by the CD-MPR and domains 3 and 9 of the CI-MPR, but lacks two
37                  Ligands precipitated by the CD-MPR appeared identical to those bound by the CI-MPR,
38 erences in binding affinity exhibited by the CD-MPR toward various lysosomal enzymes.
39  in lysosomal enzyme sorting mediated by the CD-MPR.
40                                 However, the CD-MPR binds the VHS domains more weakly than the CI-MPR
41            Mutation of these residues in the CD-MPR cytoplasmic tail to the corresponding residues in
42 zes a phenylalanine-tryptophan signal in the CD-MPR.
43 hospho-mono- or -diesters although, like the CD-MPR, it differentially recognized isomers of phosphor
44  not altered by overexpression of any of the CD-MPR constructs.
45           The extracytoplasmic domain of the CD-MPR crystallizes as a dimer, and each monomer folds i
46 s indicate that the endosomal sorting of the CD-MPR depends on the correct presentation of a diaromat
47 med the key role of Trp19 for sorting of the CD-MPR in endosomes, with Phe18, Phe13, and several neig
48 trating that the extracellular region of the CD-MPR is sufficient for high-affinity binding and that
49 ents mediated by increased expression of the CD-MPR may represent a potentially pathogenic mechanism
50 nd, but did not eliminate the ability of the CD-MPR to release ligand under acidic conditions.
51 The addition of the Phe18-Trp19 motif of the CD-MPR to the cytoplasmic tail of the lysosomal membrane
52 runcated glycosylation-deficient form of the CD-MPR, Asn81/Stop155, which has been modified to contai
53 urthermore, the C-terminal methionine of the CD-MPR, but not the C-terminal valine of the CI-MPR, inh
54 cids did not impair endosomal sorting of the CD-MPR, indicating that two aromatic residues located at
55 ions in the structure and functioning of the CD-MPR.
56 to the single extracytoplasmic domain of the CD-MPR.
57 y different quaternary conformation than the CD-MPR in a ligand-unbound state, a feature unique among
58 the total input ligands, suggesting that the CD-MPR binds a subpopulation of the Man-6-P glycoprotein
59 sCD-MPR, residues 1-154) have shown that the CD-MPR exists as a homodimer and exhibits two distinct c
60 tructurally similar to each other and to the CD-MPR and utilize a similar carbohydrate recognition me
61 omology to domains 3 and 9 as well as to the CD-MPR.
62 e modified GAAs demonstrate that, unlike the CD-MPR or domain 9 of the CI-MPR, domain 5 exhibits a 14
63 6-P-binding sites of the IGF-II/MPR with the CD-MPR implicates several residues of IGF-II/MPR domains
64 us mouse Abeta40 in L cells expressing these CD-MPR constructs but not overexpressing human APP.
65  cathepsin D more efficiently than wild-type CD-MPR.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。